Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
Leukemia Research|January 22, 2005
Expression of IFITM1 in chronic myeloid leukemia patientsCemaliye Boylu Akyerli, Meral Beksac, Michelle Holko, et al.
Molecular Cancer|June 6, 2021
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myelomaChunyan Gu, Wang Wang, Xiaozhu Tang, et al.
Leukemia & Lymphoma|October 28, 2020
Efficacy and safety of weekly carfilzomib (70 mg/m<sup>2</sup>), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studiesXavier Leleu, Meral Beksac, Takaaki Chou, et al.
Leukemia & Lymphoma|May 10, 2018
Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myelomaShaji Kumar, Brian Durie, Hareth Nahi, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 12, 2022
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic LeukemiaZehra Narli Ozdemir, Ekin Kircali, Uğur Şahin, et al.
Plos One|May 27, 2026
Innate immunogenetic synergy between KIR and Neanderthal-derived OAS variants predicts COVID-19 outcomesHasan Yalim Akin, Timur Tuncali, Emine Begum Gencer, et al.
Blood|July 20, 2002
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemiaNorbert Schmitz, Meral Beksac, Dirk Hasenclever, et al.
Haematologica|September 28, 2014
Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myelomaMeletios A Dimopoulos, Robert Z Orlowski, Thierry Facon, et al.
Haematologica|July 7, 2019
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcomeMeral Beksac, Guldane Cengiz Seval, Nicholas Kanellias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-upBo Björkstrand, Simona Iacobelli, Ute Hegenbart, et al.
Pageof 19